These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evidence of overadditive interaction between fenoterol and ipratropium bromide in the counteraction of cholinomimetic-induced tracheobronchial contractions. Bongrani S, Schiantarelli P, Papotti M, Folco GC. Arzneimittelforschung; 1981; 31(6):970-3. PubMed ID: 6455125 [Abstract] [Full Text] [Related]
23. [Effects of ipratropium bromide in aerosol administration on airway resistance and MEFV curves]. Illiano A, Tranfa CM, Giacomelli P, Cantatore D, Donato Di Paola RM, Marsico SA. Arch Monaldi; 1981; 36(3):105-17. PubMed ID: 6216870 [No Abstract] [Full Text] [Related]
24. The pulmonary hemodynamic effects of aerosols of isoproterenol and ipratropium in normal subjects and patients with reversible airway obstruction. Sackner MA, Friedman M, Silva G, Fernandez R. Am Rev Respir Dis; 1977 Dec; 116(6):1013-22. PubMed ID: 145195 [No Abstract] [Full Text] [Related]
26. [Bronchodilator effects of an aerosol anticholinergic (Sch. 1,000). Preliminary study]. Gayrard P, Orehek J, Charpin J. Mars Med; 1972 Dec; 109(11):689-91. PubMed ID: 4662230 [No Abstract] [Full Text] [Related]
27. [The measurement of airway resistance during exercise by body plethysmography before and after application of asthma-protective drugs (author's transl)]. Eisenberg BM, Linss G, Drescher E. Z Erkr Atmungsorgane; 1981 Dec; 157(3):318-22. PubMed ID: 7340218 [Abstract] [Full Text] [Related]
28. [Evaluation of respiratory function (respiratory function tests)]. Orehek J. Rev Mal Respir; 1998 Sep; 15 Suppl 2():S29-32. PubMed ID: 9809340 [No Abstract] [Full Text] [Related]
29. [The use of Sch 1000 in inhalation treatment with intermittent positive pressure of chronic obstructive respiratory diseases (author's transl)]. Beil M, Wylicil P. MMW Munch Med Wochenschr; 1975 Feb 28; 117(9):357-60. PubMed ID: 804645 [Abstract] [Full Text] [Related]
30. [Effect of atrovent on pulmonary ventilation, pulmonary gas exchange and pulmonary hemodynamics in patients with diffuse bronchostenosis]. Hawryłkiewicz I, Głuskowski J, Zieliński J. Pneumonol Pol; 1978 Jun 28; 46(6):451-5. PubMed ID: 151270 [No Abstract] [Full Text] [Related]
33. Dose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects. Wesseling GJ, Vonk JM, Greve LH, Wouters EF. Int J Clin Pharmacol Ther Toxicol; 1990 Jan 28; 28(1):33-8. PubMed ID: 2137435 [Abstract] [Full Text] [Related]
38. [Effect of the inhalation of an atropine derivative (ipratropium bromide) in powder form on respiratory mechanics in obstructive airway diseases]. Götz R, Siemon G. Prax Klin Pneumol; 1983 Oct 28; 37 Suppl 1():927-8. PubMed ID: 6227883 [No Abstract] [Full Text] [Related]
39. [Alteration in the small airway tests on asthmatics under treatment with atrovent (author's transl)]. Wuthe H, Müller E, Merker G, Vogel J, Dehnert I, Wiesner B. Z Erkr Atmungsorgane; 1980 Mar 28; 154(3):303-7. PubMed ID: 6447955 [Abstract] [Full Text] [Related]
40. [The importance of the phase angle in oscillatory measurements of resistance to breathing (author's transl)]. Korte W. Prax Klin Pneumol; 1979 Jul 28; 33(7 Suppl):845-56. PubMed ID: 547283 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]